Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon alfa-2a, ATC L03AB11 für die Zeit 01.08.2026 - 31.07.2028
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon alfa-2a, ATC L03AB11 für die Zeit 01.08.2026…”. Bids close on 5 June 2028. To qualify, bidders need at least one similar completed work, ISO 9001 and GST registration.
The work
A non-exclusive discount agreement for the substance Peginterferon alfa-2a (ATC L03AB11) to be concluded between 01.08.2026 and 31.07.2028.
- Agreement must be non-exclusive
- Must comply with § 130a Abs. 8 SGB V
Key facts
- Contract period
- 01.08.2026 to 31.07.2028
- Evaluation
- Selection criteria are stated as 'Siehe Antragsschreiben' (See application letter).
What it takes to qualify
Worth a closer look
- The text mentions a ' förmlicher Vergabeverfahren nach den Regularien des 4. Teils des GWB' but also states it does not fall under cartel procurement law. This creates some ambiguity about the formal procurement process requirements.
- The selection criteria are referenced as 'Siehe Antragsschreiben' (See application letter), which is not detailed in the provided text.
Experience
- At least 1 similar work — No specific experience requirements mentioned in the text.
Certifications and registrations
ISO 9001No mention of ISO 9001 or any other technical capability requirements in the text.
GST registrationNo mention of GST registration in the provided text.
PAN registrationNo mention of PAN registration in the provided text.
EPF registrationNo mention of EPF registration in the provided text.
ESIC registrationNo mention of ESIC registration in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenOffer letter to be submitted per email.
- VertragContract with DAK-Gesundheit's terms, including specified discounts, to be submitted per email.
- Anlage 1Filled out as part of the contract submission.
- Anlage 2Excel file listing the medicinal products to be part of the contract.